The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 11, 2006

Filed:

Oct. 15, 2002
Applicants:

Frank B. Dean, Broomfield, CO (US);

Roger S. Lasken, New Haven, CT (US);

Linhua Fang, Branford, CT (US);

A. Fawad Faruqi, Guilford, CT (US);

Osama A. Alsmadi, Guilford, CT (US);

Mark D. Driscoll, Wallingford, CT (US);

Seiyu Hosono, Mamaroneck, NY (US);

Michele Wisniewski, Hamden, CT (US);

Wanmin Song, Branford, CT (US);

Inventors:

Frank B. Dean, Broomfield, CO (US);

Roger S. Lasken, New Haven, CT (US);

Linhua Fang, Branford, CT (US);

A. Fawad Faruqi, Guilford, CT (US);

Osama A. Alsmadi, Guilford, CT (US);

Mark D. Driscoll, Wallingford, CT (US);

Seiyu Hosono, Mamaroneck, NY (US);

Michele Wisniewski, Hamden, CT (US);

Wanmin Song, Branford, CT (US);

Assignee:

Qiagen GmbH, Hilden, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12P 19/34 (2006.01);
U.S. Cl.
CPC ...
Abstract

Disclosed are compositions and a method for amplification of nucleic acid sequences of interest. The disclosed method generally involves replication of a target sequence such that, during replication, the replicated strands are displaced from the target sequence by strand displacement replication of another replicated strand. In one form of the disclosed method, the target sample is not subjected to denaturing conditions. It was discovered that the target nucleic acids, genomic DNA, for example, need not be denatured for efficient multiple displacement amplification. The primers used can be hexamer primers. The primers can also each contain at least one modified nucleotide such that the primers are nuclease resistant. The primers can also each contain at least one modified nucleotide such that the melting temperature of the primer is altered relative to a primer of the same sequence without the modified nucleotide(s). The DNA polymerase can be φ29 DNA polymerase.


Find Patent Forward Citations

Loading…